Literature DB >> 18443915

Differential impairment of psychomotor efficiency and processing speed in patients with chronic kidney disease.

Sarbjit V Jassal1, Janet Roscoe, Denise LeBlanc, Gerald M Devins, Sean Rourke.   

Abstract

BACKGROUND: Cognitive impairment has been documented in patients with chronic kidney disease. In a recent paper, improvements in cognitive function were seen in hemodialysis (HD) patients switched from conventional HD to nocturnal HD, in two of three domains of cognitive function. Based on these findings, we hypothesized that functional decline may occur differentially in some domains more than others.
METHODS: Using a cross-sectional study design, patients optimized on medical treatment at a predialysis clinic were tested using a battery of neuropsychological (NP) tests measuring three domains of cognitive functioning-attention & working memory skills; psychomotor efficiency & processing speed; and learning efficiency. Clinical subjective symptoms for cognitive functioning and depression were measured using the Patient's Assessment of Own Functioning (PAOF) inventory and the Beck Depression Inventory (BDI).
RESULTS: One hundred and three patients aged 64.6+/-12.4 years were recruited. Of these, 40% were diabetic, with a mean Charlson comorbidity score of 4.4+/-2.1. Depression (defined as >16 on the BDI score) was seen in 11 patients. After adjustment for comorbid diseases, hemoglobin, the use of neurodepressor medication, and parathyroid hormone (PTH) values, renal function was negatively correlated with psychomotor efficiency & processing speed, but not with attention & working memory or learning efficiency scores.
CONCLUSION: Chronic kidney disease is associated with a decline in psychomotor efficiency & processing speed, but not with attention & working memory or learning efficiency.

Entities:  

Mesh:

Year:  2008        PMID: 18443915     DOI: 10.1007/s11255-008-9375-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  23 in total

1.  Improvement of brain function in hemodialysis patients treated with erythropoietin.

Authors:  G Grimm; F Stockenhuber; B Schneeweiss; C Madl; J Zeitlhofer; B Schneider
Journal:  Kidney Int       Date:  1990-09       Impact factor: 10.612

2.  Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care.

Authors:  A T Beck; D Guth; R A Steer; R Ball
Journal:  Behav Res Ther       Date:  1997-08

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Electrophysiological and neurobehavioral responses to therapy: the National Cooperative Dialysis Study.

Authors:  P E Teschan; J R Bourne; R B Reed; J W Ward
Journal:  Kidney Int Suppl       Date:  1983-04       Impact factor: 10.545

5.  Normalizing hematocrit in dialysis patients improves brain function.

Authors:  J L Pickett; D C Theberge; W S Brown; S U Schweitzer; A R Nissenson
Journal:  Am J Kidney Dis       Date:  1999-06       Impact factor: 8.860

6.  The course of adult intellectual development.

Authors:  K W Schaie
Journal:  Am Psychol       Date:  1994-04

Review 7.  Effects of epoetin alfa on the central nervous system.

Authors:  A Cerami; M L Brines; P Ghezzi; C J Cerami
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

8.  Chronic kidney disease and cognitive impairment in menopausal women.

Authors:  Manjula Kurella; Kristine Yaffe; Michael G Shlipak; Nanette K Wenger; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2005-01       Impact factor: 8.860

9.  Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients.

Authors:  D L Wolcott; D K Wellisch; J T Marsh; J Schaeffer; J Landsverk; A R Nissenson
Journal:  Am J Kidney Dis       Date:  1988-10       Impact factor: 8.860

10.  Patient-reported sleep difficulty and cognitive function during the first year of dialysis.

Authors:  Nancy G Kutner; Rebecca Zhang; Yijian Huang; Donald L Bliwise
Journal:  Int Urol Nephrol       Date:  2007-03-07       Impact factor: 2.370

View more
  15 in total

1.  Risk for cognitive impairment across 22 measures of cognitive ability in early-stage chronic kidney disease.

Authors:  Rachael V Torres; Merrill F Elias; Stephen Seliger; Adam Davey; Michael A Robbins
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

Review 2.  Kidney disease and cognitive function.

Authors:  Merrill F Elias; Gregory A Dore; Adam Davey
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

3.  The impact of hemodialysis on cognitive dysfunction in patients with end-stage renal disease: a resting-state functional MRI study.

Authors:  Hui Juan Chen; Rongfeng Qi; Xiang Kong; Jiqiu Wen; Xue Liang; Zhe Zhang; Xue Li; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-07-07       Impact factor: 3.584

Review 4.  Neuropsychiatric complications of chronic kidney disease.

Authors:  Rory McQuillan; Sarbjit V Jassal
Journal:  Nat Rev Nephrol       Date:  2010-06-22       Impact factor: 28.314

5.  Differential Attention Functioning in Pediatric Chronic Kidney Disease.

Authors:  Peter J Duquette; Debbie S Gipson; Stephen R Hooper
Journal:  Front Hum Neurosci       Date:  2022-06-24       Impact factor: 3.473

Review 6.  Adult chronic kidney disease: neurocognition in chronic renal failure.

Authors:  Nikhil S Koushik; Steven F McArthur; Anne D Baird
Journal:  Neuropsychol Rev       Date:  2009-08-25       Impact factor: 7.444

7.  Association of blood pressure variability and neurocognition in children with chronic kidney disease.

Authors:  Marc B Lande; Susan R Mendley; Matthew B Matheson; Shlomo Shinnar; Arlene C Gerson; Joshua A Samuels; Bradley A Warady; Susan L Furth; Stephen R Hooper
Journal:  Pediatr Nephrol       Date:  2016-06-05       Impact factor: 3.714

8.  Altered pattern of spontaneous brain activity in the patients with end-stage renal disease: a resting-state functional MRI study with regional homogeneity analysis.

Authors:  Xue Liang; Jiqiu Wen; Ling Ni; Jianhui Zhong; Rongfeng Qi; Long Jiang Zhang; Guang Ming Lu
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

9.  Everyday discrimination and subsequent cognitive abilities across five domains.

Authors:  Laura B Zahodne; Emily P Morris; Neika Sharifian; Afsara B Zaheed; A Zarina Kraal; Ketlyne Sol
Journal:  Neuropsychology       Date:  2020-08-03       Impact factor: 3.295

10.  Prevalence and pattern of neurocognitive impairment in nigerians with stages 3 to 5 chronic kidney disease.

Authors:  U E Williams; M O Owolabi; A Ogunniyi; E O Ezunu
Journal:  ISRN Neurol       Date:  2013-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.